Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in PVLA — Palvella Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in PVLA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,344,417
+$2,344,417 QoQ
Shares Held
18,808
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PVLA Over Time

Shares Held

Position Value (USD)

Derivatives in PVLA

reported options exposure · as of Mar 31, 2026
CallValue
$17,650,440
CallShares
141,600
PutValue
$4,051,125
PutShares
32,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. PVLA ranks #100 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PVLA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $17,650,440 141,600
2026-03-31 $2,344,417 18,808
2026-03-31 $4,051,125 32,500
2025-12-31 $3,998,394 38,200
2025-09-30 $984,233 15,700
2025-09-30 $319,719 5,100
2025-09-30 $502,021 8,008
2025-06-30 $223,146 9,900
2025-06-30 $391,835 17,384
2025-03-31 $3,201,720 114,388